LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

5th November 2026

CPHI Middle East and BIO Middle East will now take place in Riyadh from 26-28 April 2027

5th November 2026

Concept Life Sciences appoints industry veteran Dean Bornilla as Chief Commercial Officer to drive international expansion

3rd November 2026

Axplora partners with Abionyx to support development of CER-001

3rd November 2026

Shilpa CDMO to invest $50 million in commercial peptide manufacturing

3rd November 2026

Lonza to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US Presence

29th October 2026

Lonza Further Expands Bioconjugation Manufacturing to Support Growing ADC Demand

28th October 2026

THE GOLDEN AGING REVOLUTION: HOW INDENA’S BOTANICAL INNOVATIONS REDEFINE LONGEVITY AND HEALTHY APPEARANCE

28th October 2026

Piramal Pharma Solutions’ Pithampur, India Site Wins Annual Excellence in Patient Centricity Award for Linking Every Batch to Patient Impact

27th October 2026

CordenPharma Achieves EcoVadis Gold Medal for Group-Wide Sustainability Performance

27th October 2026

Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Programme from Enzene

27th October 2026

DFE Pharma appoints Peter Rose as new Chief Operating Officer

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations